172 related articles for article (PubMed ID: 32943033)
1. Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer.
Wu C; Wu Z; Tian B
BMC Surg; 2020 Sep; 20(1):207. PubMed ID: 32943033
[TBL] [Abstract][Full Text] [Related]
2. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer.
Yunpeng P; Lingdi Y; Xiaole Z; Dongya H; Le H; Zipeng L; Kai Z; Chaoqun H; Yi M; Feng G; Qiang L
BMC Cancer; 2023 Jun; 23(1):548. PubMed ID: 37322417
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
5. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer.
Liu X; Chen B; Chen J; Sun S
BMC Cancer; 2021 Mar; 21(1):335. PubMed ID: 33789615
[TBL] [Abstract][Full Text] [Related]
6. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer.
Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
[TBL] [Abstract][Full Text] [Related]
7. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
8. Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model.
Yan X; Wan H; Hao X; Lan T; Li W; Xu L; Yuan K; Wu H
Cancer Manag Res; 2019; 11():273-283. PubMed ID: 30643453
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer.
Chen G; Long J; Zhu R; Yang G; Qiu J; Zhao F; Liu Y; Tao J; Zhang T; Zhao Y
Front Cell Dev Biol; 2021; 9():709669. PubMed ID: 35087823
[No Abstract] [Full Text] [Related]
10. Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis.
Li J; Liu L
BMC Cancer; 2019 Jul; 19(1):726. PubMed ID: 31337369
[TBL] [Abstract][Full Text] [Related]
11. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
12. Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients.
Wu J; Zhou L; Huang L; Gu J; Li S; Liu B; Feng J; Zhou Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):4. PubMed ID: 28057025
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer.
Zhang Z; Gu J; Yin M; Wang D; Ma C; Du J; Lin Z; Hu S; Wang X; Li Y; Tan G; Luo H; Wei G
Biomed Res Int; 2020; 2020():1570862. PubMed ID: 33015155
[TBL] [Abstract][Full Text] [Related]
15. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
[TBL] [Abstract][Full Text] [Related]
16. Predicting postoperative prognosis of pancreatic cancer using a computed tomography-based radio-clinical model: exploring biologic functions.
Yu C; Ruan Y; Yu L; Wang X; Hu Z; Zhu G; Huang T
J Gastrointest Surg; 2024 Apr; 28(4):458-466. PubMed ID: 38583896
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a prognostic prediction system based on tumor microenvironment of pancreatic cancer.
Feng Y; Li P; Yang F; Xu K
Medicine (Baltimore); 2022 Dec; 101(51):e32364. PubMed ID: 36595826
[TBL] [Abstract][Full Text] [Related]
18. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
Zhang J; Gong Z; Gong Y; Guo W
Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Yin X; Kong L; Liu P
Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
